Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03205046
Title A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Acerta Pharma BV
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Research Site Fairway Kansas 66205 United States Details
Research Site Bethesda Maryland 20892 United States Details
Research Site Rochester Minnesota 55902 United States Details
Research Site Omaha Nebraska 68198 United States Details
Research Site Hackensack New Jersey 07601 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Seattle Washington 98109 United States Details
Research Site Headington OX3 7LJ United Kingdom Details
Research Site London EC1A 7BE United Kingdom Details
Research Site Nottingham NG5 1PB United Kingdom Details
Research Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field